Elutia (ELUT) Revenue Growth (3y) (2022 - 2026)
Elutia (ELUT) Revenue Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 8.07% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 9.66% |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 14.78% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 10.83% |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 14.51% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 3.20% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 25.44% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 8.05% |
| 10 | Elutia | 39.84 Mn | 19.94 Mn | 1.45 Mn | -27.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.31% |
| Dec 31, 2025 | -20.81% |
| Sep 30, 2025 | -17.18% |
| Jun 30, 2025 | -20.87% |
| Mar 31, 2025 | -36.44% |
| Dec 31, 2024 | -36.23% |
| Sep 30, 2024 | -31.68% |
| Jun 30, 2024 | -19.72% |
| Mar 31, 2024 | -19.61% |
| Dec 31, 2023 | -22.18% |
| Sep 30, 2023 | -19.57% |
| Jun 30, 2023 | -9.54% |
| Mar 31, 2023 | -13.46% |
| Dec 31, 2022 | -18.24% |
| Sep 30, 2022 | -19.32% |